Ignite Creation Date:
2024-05-06 @ 3:41 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02343679
Status:
WITHDRAWN
Last Update Posted:
2017-02-01
First Post:
2014-12-03
Brief Title:
Novartis PhII Ceritinib LDK378 in RR ALK Hem Malignancies
Sponsor:
Anne Beaven MD
Organization:
Duke University
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hematologic Malignancies |
Keywords: